JYOTHY LABS LTD.
NSE : JYOTHYLABBSE : 532926ISIN
CODE : INE668F01031Industry : Household & Personal ProductsHouse
: Jyothy Labs
BSE446.953.9 (+0.88 % )
PREV CLOSE (Rs.) 443.05
OPEN PRICE (Rs.) 446.95
BID PRICE (QTY) 445.70 (8 )
OFFER PRICE (QTY) 446.70 (1 )
VOLUME 101
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE446.05 3.1 (+0.7 % )
PREV CLOSE(Rs.) 442.95
OPEN PRICE (Rs.) 446.05
BID PRICE (QTY) 446.05 (37 )
OFFER PRICE (QTY) 446.70 (300 )
VOLUME 155
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 15-May-2024 | Jyothy Labs informs about financial results | <div style="text-align: justify;">Jyothy Labs has informed that it attached the Financial Results for the Quarter and Year ended March 31, 2024.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 15-May-2024 | Jyothy Labs informs about outcome of board meeting | <div style="text-align: justify;">Jyothy Labs has informed that the Board of Directors of the Company at its meeting held today, which commenced at 10:30 am and concluded at 1:20 pm have: approved the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31, 2024. Accordingly, they are enclosing the following: Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024; Auditors Report issued by B S R & Co. LLP, Statutory Auditors of the Company on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024. Further, the report of B S R & Co. LLP, Statutory Auditors of the Company, is with the unmodified opinion with respect to the Audited Financial Results (Standalone and Consolidated) for the financial year ended March 31, 2024.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 03-May-2024 | Jyothy Labs informs about board meeting | <p style="text-align: justify;">Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jyothy Labs has informed that a Meeting of the Board of Directors of the company is scheduled to be held on Wednesday, May 15, 2024, to: 1) consider and approve the Audited Financial Results of the Company on Standalone and Consolidated basis for the quarter and year ended March 31, 2024 together with the Auditors' Reports thereon by the Statutory Auditors of the Company; and 2) consider recommendation of dividend, if any, on the equity shares of the Company for the financial year 2023-24. The said information is also available on the website of the Company at www.jyothylabs.com.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 03-May-2024 | Jyothy Labs informs about conference call | <p style="text-align: justify;">Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jyothy Labs has informed that the Company is organizing a conference call for analyst/ investors on Wednesday, May 15, 2024 at 16:00 hours IST, subsequent to declaration of its Audited Financial Results for the quarter and year ended March 31, 2024 to discuss the Company's financial performance for the said period and the way forward. The details to join Conference Call is attached. Further, the aforesaid information is also available on the website of the Company at www.jyothylabs.com.</p><div>The above information is a part of company's filings submitted to BSE.</div> |
| 27-Mar-2024 | Jyothy Labs informs about issuance of duplicate share certificate | <p style="text-align: justify;">Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jyothy Labs has informed that Link Intime India, the Registrar and Share Transfer Agent (RTA) has intimated the Company on March 26, 2024 regarding issue of duplicate share certificate to the shareholder details of which are enclosed.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 16-Mar-2024 | Jyothy Labs informs about issuance of duplicate share certificate | <p style="text-align: justify;">Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jyothy Labs has informed that Link Intime India, the Registrar and Share Transfer Agent (RTA) has intimated the Company on March 15, 2024 regarding issue of duplicate share certificate to the shareholder details of which are enclosed.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE. </p> |
| 02-Mar-2024 | Jyothy Labs informs about details of loss of certificate | <div style="text-align: justify;">Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jyothy Labs has informed that Link Intime India, the Registrar and Share Transfer Agent (RTA) has intimated the Company on March 1, 2024 regarding receipt of letter from the shareholder informing loss of original Share Certificate. Name of the Shareholder: Satpal Bhola (Folio No. 0013784)</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 26-Feb-2024 | Jyothy Labs informs about disclosure | <p style="text-align: justify;">Jyothy Labs has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Franklin Templeton Mutual Fund.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 07-Feb-2024 | Jyothy Labs informs about newspaper publication | <div style="text-align: justify;">Pursuant to Regulation 30 read with Part A of Schedule III and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in compliance with all applicable circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India in this regards, Jyothy Labs has enclosed copies of newspaper advertisement published in today's i.e. February 7, 2024 Financial Express (English - All Edition) and Loksatta (Marathi - Mumbai Edition), pertaining to dispatch of Postal Ballot Notice. Further, the aforesaid information is also available on the website of the Company at www.jyothylabs.com. </div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 03-Feb-2024 | Jyothy Labs submits earnings call transcript | <div style="text-align: justify;">Jyothy Labs has informed that pursuant to Regulation 30(6) read with Part A of Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Transcript of the earnings conference call held on Wednesday, January 31, 2024 for analyst/ investors to discuss the Un-audited Financial Results for the quarter and nine months ended December 31, 2023 and the way forward, is enclosed. Further, the aforesaid information is also available on the website of the Company at www.jyothylabs.com</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE. </div><div style="text-align: justify;"><br></div> |
